Economics Faculty Database
Economics
Arts & Sciences
Duke University
 HOME > Arts & Sciences > Economics > Faculty    Search Help Login pdf version printable version 

Publications of John M Vernon    :recent first  alphabetical  combined  bibtex listing:

Books

  1. J.M. Vernon, T. Naylor, Microeconomics and Decision Models of the Firm (1969), pp. Pp.xiii, 482, New York: Harcourt, Brace and World, Inc., 1969 (Spanish Edition, Economia de la Empresa (Buenos Aires: Amorrortu Editores, 1973).)
  2. J.M. Vernon, Public Investment Planning in Civilian Nuclear Power (1971), pp. Pp. xiv, 167, Durham, North Carolina: Duke University Press
  3. J.M. Vernon, T. Naylor and E. Byrne, Introduction to Linear Programming (1971), pp. Pp.xii, 229, Belmont, California: Wadsworth Publishing Company
  4. J.M. Vernon, Market Structure and Industrial Performance: A Review of Statistical Findings (1972), pp. Pp.xiii, 140, Boston: Allyn and Bacon
  5. J.M. Vernon, H. Grabowski, The Impact of Regulation on Industrial innovation (1979), pp. Pp.xii, 64, Washington, D.C.: National Academy of Sciences
  6. J.M. Vernon, T. Naylor and K. Wertz, Managerial Economics: Corporate Economics and Strategy (1983), pp. Pp.xv, 445, New York: McGraw-Hill
  7. J.M. Vernon, H. Grabowski, The Regulation of Pharmaceuticals: Balancing the Benefits and Risks (1983), pp. Pp.iv, 74, Washington, D.C.: American Enterprise Institute (3rd ed, 2000.)
  8. J.M. Vernon, H. Grabowski, The Search for New Vaccines: The Effects of the Vaccines for Children Program (1997), pp. Pp.vii, 75, Washington, D.C.: The AEI Press
  9. J.M. Vernon with Kip Viscusi and Joe Harrington, Economics of Regulation and Antitrust (2000), MIT Press (3rd edition.)

Papers Published

  1. J.M. Vernon, Henry Grabowski, and Joe DiMasi, "Returns on R&D for 1990s New Drug Introductions", Pharmacoeconomics, vol. Supplement 3 (2002)

Papers Submitted

  1. J.M. Vernon, Joe DiMasi and Henry Grabowski, R&D Costs and Reurns by Therapeutic Category (2004)

Journal Articles

  1. J.M. Vernon, Benefits and Costs of Advanced Nuclear Power Reactors, Applied Economics, Vol.I, no.1 (1969)
  2. J.M. Vernon, T. Naylor and N. Rives, An Econometric Model of the Tobacco Industry, Review of Economics and Statistics (May, 1969)
  3. J.M. Vernon,E. Sasser, Marketing Simulation Models: The Problem of Specification Error, A. Schrieber, ed., Corporate Simulation Models (1970), Seattle, Washington: University of Washington Press
  4. J.M. Vernon, D. Graham, Profitability of Monopolization by Vertical Integration, Journal of Political Economy (1971) (Reprinted in B.S. Yamey, ed., Economics of Industrial Structure: Selected Readings (Penguin Modern Economics Series, 1973).)
  5. J.M. Vernon, , Promotion, and Market Share Stability in the Pharmaceutical Industry, Journal of Industrial Economics (July, 1971)
  6. J.M. Vernon, R. Nourse, Profit Rates and Market Structure of Advertising Intensive Firms, Journal of Industrial Economics (September, 1973)
  7. J.M. Vernon, A Note on the Invention Production Function, Les Proportions et Intensities de Facteurs (1974), Nanterre, France: Centre National De La Recherche Scientifique
  8. J.M. Vernon, P. Gusen, Technical Change and Firm Size: The Pharmaceutical Industry, Review of Economics and Statistics (August, 1974)
  9. J.M. Vernon, Structural Effects of Regulation on Innovation in the Ethical Drug Industry, in Essays on Industrial Organization in Honor of Joe Bain, edited by R.T. Masson and P.D. Qualls, eds (1976), Cambridge, Mass.: Ballinger
  10. J.M. Vernon, H. Grabowski and L. Thomas, The Effects of Regulatory Policy on the Incentives to Innovate, in Impact of Public Policy on Drug Innovation and Pricing, edited by E.A. Link and S. Mitchell (1976), Washington: D.C.: American University
  11. J.M. Vernon, H. Grabowski, Consumer Protection Regulation in Ethical Drugs, American Economic Review (February, 1977)
  12. J.M. Vernon, H. Grabowski and L. Thomas, Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry, Journal of Law and Economics (April, 1978)
  13. J.M. Vernon, H. Grabowski, Consumer Product Safety Regulation, American Economic Review (May, 1978)
  14. J.M. Vernon, H. Grabowski, New Studies on Market Definition, Concentration, Theory of Supply, Entry, and Promotion, in Issues in Pharmaceutical Economics, edited by R.I. Chien (1979), Cambridge, Mass.: Ballinger
  15. J.M. Vernon, The Effects of Product Quality Regulation on Innovation in the U.S. Pharmaceutical Industry, Final Report for the National Science Foundation Grant PRA 75-19823 (1979), National Technical Information Services, Washington, D.C.
  16. J.M. Vernon, H. Grabowski, Substitution Laws and Innovation in the Pharmaceutical Industry, Law and Contemporary Problems (Spring, 1979)
  17. J.M. Vernon, H. Grabowski, The Determinants of R and D Expenditures in the Pharmaceutical Indsutry, in Drugs and Health, edited by R. Helms (1981), Washington, D.C.: American Enterprise Institute
  18. J.M. Vernon, H. Grabowski, The Pharmaceutical Industry, in Government and Technical Change: A Cross Industry Analysis, edited by R. Nelson (1982), New York: Pergamon Press
  19. J.M. Vernon, H. Grabowski, A Sensitivity Analysis of Expected Profitability of Pharmaceutical Research and Development, Managerial and Decision Economics (March, 1982)
  20. J.M. Vernon, H. Grabowski, The Impact of Patent and Regulatory Policies on Drug Innovation, Medical Marketing (October, 1983)
  21. J.M. Vernon, H. Grabowski, A Computer Simulation Model of Pharmaceutical Innovation, in The Economics of the Pharmaceutical Industry, edited by B. Lindgren (1984), The Swedish Institute for Health Economics, Lund, Sweden
  22. J.M. Vernon, H. Grabowski, Studies on Drug Substitution, Patent Policy, and Innovation in the U.S. Pharmaceutical Industry, Final Report for the National Science Foundation Grant PB-85-109700 (1985), National Technical Information Services, Washington, D.C.
  23. J.M. Vernon, The Economics of Patents and the Pharmaceutical Industry, International Symposium on Pharmaceutical Patents (September, 1985), National Science Council, Taipei, Taiwan
  24. J.M. Vernon, H. Grabowski, Longer Patents for Lower Imitation Barriers, American Economic Review (May, 1986)
  25. J.M. Vernon, H. Grabowski, Pioneers, Imitators, and Generics: A Simulation Model of Schumpeterian Competition, Quarterly Journal of Economics (August, 1987)
  26. J.M. Vernon, H. Grabowski, A New Look at the Returns and Risks to Pharmaceutical R&D, Management Science (July, 1990) (Reprinted in D. Lamdin, ed., The Managerial Economics Reader (Miami: Kolb Publishing, 1993).)
  27. J.M. Vernon, D. Graham, A Note on Decentralized Natural Monopoly Regulation, Southern Economic Journal (July, 1991)
  28. J.M. Vernon, H. Grabowski, The Costs and Returns to Pharmaceutical Research and Development, Rivista Internazionale di Scienze Sociali (September, 1992)
  29. J.M. Vernon, H. Grabowski, Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act, Journal of Law and Economics (October, 1992)
  30. J.M. Vernon, H. Grabowski, Innovation and Structural Change in Pharmaceuticals and Biotechnology, Industrial and Corporate Change, vol. 3 no. 2 (1994)
  31. J.M. Vernon, H. Grabowski, Returns to R&D on New Drug Introductions in the 1980s, Journal of Health Economics (November, 1994)
  32. J.M. Vernon, J. DiMasi and H. Grabowski, R&D Costs, Innovative Output, and Firm Size in the Pharmaceutical Industry, International Journal of the Economics of Business, vol. 2 no. 2 (1995)
  33. J.M. Vernon, H. Grabowski, Prospects for Returns to Pharmaceutical R&D under Health Care Reform, in Competitive Strategies in the Pharmaceutical Industry, edited by R. Helms (1996), Washington, D.C.: American Enterprise Institute
  34. J.M. Vernon, H. Grabowski, Longer Patents for Increased Generic Competition: The Waxman-Hatch Act after One Decade, Pharmacoeconomics, supplement 2 (1996)
  35. J.M. Vernon with H. Grabowski, "Effective Patent Life in Pharmaceuticals", International Journal of Technology Management, vol. 19 no. 1/2 (2000)
  36. J.M. Vernon with H. Grabowski, "The Determinants of Pharmaceutical Research and Development Expenditures", Journal of Evolutionary Economics, vol. 10 (2000), pp. 201-205

Other

  1. J.M. Vernon,M. McElroy, A Note on Estimation in Market Structure Performance Studies, American Economics Review (September, 1973)
  2. J.M. Vernon, S. Peltzman, Review of Regulation of Pharmaceutical Innovation: The 1962 Amendments, Journal of Economic Literature (June, 1975)
  3. J.M. Vernon, D. Graham, The Economics of the Network-Affilate Relationship: Comment, American Economic Review (December, 1975)
  4. J.M. Vernon, Review of U.S. Oil Pipeline Markets: Structure, Pricing and Public Policy, Journal of Economic Literature (September, 1984) (By J.A. Hansen.)
  5. J.M. Vernon with H. Grabowski, "The Distribution of Sales Revenues from Pharmaceutical Innovation", Pharmacoeconomics, vol. supplement 1 (2000)
  6. J.M. Vernon with H. Grabowski, "Pressures from the Demand Side: Changing Market Dynamics and Industrial Structure", in Consolidation and Competition in the Pharmaceutical Industry, edited by Hannah E. Kettler (2001), Office of Health Economics, London
Duke University * Arts & Sciences * Economics * Faculty * Research * Staff * Master's * Ph.D. * Reload * Login